Global trial transparency is becoming essential in a shifting regulatory landscape. Life sciences organizations face increasing pressure to share accurate, timely information about clinical trials. Transparency is not just a compliance requirement—it builds trust with patients, regulators, and the public. Leading with transparent and open practices helps organizations stay ahead while supporting ethical and responsible research, as explained by Christopher Throgmorton.